Severe pulmonary haemorrhage syndrome in leptospirosis in a returning traveller

Infection. 2019 Feb;47(1):125-128. doi: 10.1007/s15010-018-1220-7. Epub 2018 Sep 18.

Abstract

Clinical presentation of leptospirosis ranges from asymptomatic infection to fulminant, life-threatening disease. Pulmonary involvement in terms of severe pulmonary haemorrhage syndrome (SPHS) has recently become a more frequently reported facet of leptospirosis and correlates with high mortality rates. It has not yet been described in returning German travellers. We present a case of a healthy young man developing massive pulmonary haemorrhage and severe ARDS requiring mechanical ventilation and high-dose catecholamines after travelling to Indonesia. Leptospirosis was verified by blood PCR as well as serology and treated with high-dose, intravenous penicillin. Outcome was favourable, the patient recovered completely. Leptospirosis and SPHS should be taken into account as an emerging infectious disease in patients with fever and lung involvement.

Keywords: Emerging infectious disease; Leptospirosis; Severe pulmonary haemorrhage syndrome; Travel medicine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Communicable Diseases, Emerging / diagnosis
  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / pathology
  • Germany
  • Hemorrhage / diagnosis*
  • Hemorrhage / drug therapy
  • Hemorrhage / microbiology
  • Hemorrhage / pathology
  • Humans
  • Indonesia
  • Leptospirosis / diagnosis*
  • Leptospirosis / drug therapy
  • Leptospirosis / microbiology
  • Leptospirosis / pathology
  • Lung Diseases / diagnosis*
  • Lung Diseases / drug therapy
  • Lung Diseases / microbiology
  • Lung Diseases / pathology
  • Male
  • Penicillins / therapeutic use
  • Travel

Substances

  • Anti-Bacterial Agents
  • Penicillins